collected from the
samples using the Complete-Lysis M solution (Roche Diagnostics, Indianapolis,
IN). Soluble protein concentration was determined using the NanoDrop
2000 Spectrophotometer. Total cellular proteins were separated using
8% and 10% SDS-PAGE and transferred to Immobilon-FL membranes (Millipore
Corporation, Bedford, MA). After blocked with 5% nonfat milk, the
membrane was probed with different primary antibodies including anti-SERCA2a
(1:500) (LSBio, Seattle, WA), anti α-MHC (1:150) (Santa Cruz,
Dallas, TX) and β-MHC (1:500) (Bioss, Woburn, MA), anti-Actinin
(1:500) (Abcam, Cambridge, MA), anti TnT (1:1000) (Sigma-Aldrich,
St. Louis, MO), and anti β-actin (1:1000) (Cell Signaling, Beverly,
MA). The secondary antibody was Cy3goat anti-Rabbit IgG (1:500) (Life
Technologies, Grand Island, NY) and Cy5 goat antimouse IgG1 (1:500)
(Abcam, Cambridge, MA). The labeled membrane was finally visualized
and photographed using a Typhon 9400 system and NIH ImageJ software.
Protein content was compared between the CCCM control and CCCM stimulated
groups. In contrast to the RNA analysis, we did not include parallel
protein content from ED16 chick embryonic ventricles in this analysis.